Skip to content
MarketScale
‹ Back to IndustriesSciences

SupplySide West 2021: CEO Insights

Deerland Probiotics and Enzymes, led by CEO Scott Ravitch, participated in Supply Side West 2021 to reconnect with industry stakeholders. The company showcased innovative products like Pre4 Pro and DE111, supported by clinical studies. Deerland continues to expand its product portfolio and scientific research, offering customer-centric solutions.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · DeerlandEnzymesProbioticSupplyside West
Share
SupplySide West 2021: CEO Insights

Key takeaways

01

Deerland introduced Pre4 Pro, a prebiotic effective in small quantities without causing digestive discomfort.

02

DE111 probiotic benefits digestive health and immunity, usable in various forms including gummies and kombucha.

03

Deerland's focus includes conducting clinical studies and co-creating formulations with customers.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

Deerland Probiotics and Enzymes, led by CEO Scott Ravitch, is thrilled to be back at Supply Side West in Las Vegas. This prestigious trade show is a crucial event for the company, providing an opportunity to reconnect with important customers, prospective clients, suppliers, and industry professionals. With a focus on branded clinical products, Deerland Probiotics and Enzymes is showcasing innovative solutions that make a measurable difference in people’s lives.

One of the standout products is Pre4 Pro, a unique prebiotic that works effectively in small quantities, just 15 milligrams. Unlike mainstream prebiotics, Pre4 Pro doesn’t cause digestive discomfort. Additionally, the flagship DE111 probiotic offers tremendous benefits for digestive well-being and immunity. This versatile probiotic finds applications in various forms, from traditional supplements like capsules and tablets to more exciting options such as gummies, kombuchas, and food and beverage products. Another highlight is Solarplast, a potent antioxidant product that contributes to beauty from within. All these offerings are backed by robust human clinical studies, a testament to Deerland’s commitment to science and substantiated claims.

Over the past two years, Deerland Probiotics and Enzymes has made remarkable progress despite the challenges posed by the COVID-19 pandemic. The company has focused on conducting clinical studies and expanding its product portfolio. With six completed studies, including a groundbreaking germination study for DE111, Deerland has solid scientific evidence to support its offerings. They have also continued new product development, introducing Munispor for immune health and having three more products in the pipeline for launch. The integration of the Bifidin acquisition in 2019 has further enriched Deerland’s capabilities.

Looking ahead to 2021 and beyond, Deerland Probiotics and Enzymes remains committed to providing competitive differentiation and delivering exceptional value to its customers. By offering consultative solutions, the company goes beyond being an ingredients or manufacturing provider. Their team takes the time to understand customers’ goals and consumer needs, co-creating the best formulations for their products. This customer-centric approach has enabled Deerland’s partners to launch successful brands and attract new customers. The company’s culture, rooted in core values and a mission to make a measurable difference in people’s lives, serves as a guiding force in every decision and action.

Deerland Probiotics and Enzymes is dedicated to advancing science, expanding their portfolio, and building strong partnerships. With an unwavering commitment to quality, performance, and safety, they create innovative solutions that address emerging market needs. The company is grateful for the trust and faith that customers place in them and takes pride in the positive impact their products and services have on people’s lives.

Join Deerland Probiotics and Enzymes on their mission to make a measurable difference in the quality of people’s lives. Experience their scientific expertise, consultative approach, and commitment to excellence.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Lab automation ROI hinges on integration, not instrument sensitivity claims

Lab automation ROI hinges on integration, not instrument sensitivity claims

At ADLM 2026, Waters and LabCollector delivered a clear message for lab leaders: the limiting factor in automation is often integration, not hardware. Waters introduced the Xevo TQ Absolute XR IVD mass spectrometer and is positioning it at “5x greater sensitivity” versus in-class instruments, according to SelectScience, but that advantage only carries through if sample prep, calibration and QA, middleware rules, and LIMS result review can keep pace. In parallel, LabCollector announced an AI Co-Scientist feature set for natural-language search, knowledge retrieval, and AI-assisted content creation inside ELN and LIMS workflows, also reported by SelectScience, shifting attention from pipetting speed to retrieval, approval, permissions, and versioning in systems that sit on the documentation path. The Scientist’s overview of semi-automated versus fully automated approaches reinforces the point: labs can automate in modules, but they have to run automation as one system.

  • 01The bottleneck in automation is often the handoff, instrument to middleware to LIMS, so sensitivity and throughput gains depend on interfaces and downstream review as much as the instrument spec.
  • 02Waters’ “5x greater sensitivity” positioning and LabCollector’s AI Co-Scientist both point to integration work, sample prep, calibration and QA, middleware rules, and LIMS result review, as the gating factor for ROI.
  • 03As ELN/LIMS add conversational search and AI-assisted content creation, speed gains move from pipetting to retrieval, approval, permissions, and versioning inside systems that sit in regulated or audited workflows.

Sep 3, 2026

AeroVironment to co-design three autonomous helicopters for NASA's SkyFall Mars mission

AeroVironment to co-design three autonomous helicopters for NASA's SkyFall Mars mission

AeroVironment’s MacCready Works has been contracted to build three autonomous Mars helicopters for NASA's SkyFall mission. This development highlights the company's capabilities in aerospace-grade autonomy and avionics integration. The project shows a strong connection between aerospace and defense industries in terms of supply chain management.

  • 01AeroVironment is co-designing and co-manufacturing three autonomous helicopters for NASA's SkyFall Mars mission with JPL.
  • 02SkyFall will use a 'SkyFall maneuver' where three helicopters are released from a carrier spacecraft, separate, deploy, descend, and land under their own power, avoiding a dedicated lander or host rover.
  • 03AeroVironment leads rotor systems, airframes, structures, avionics integration, and payload provisions, while JPL leads the power system, electronics, algorithms, and software.

Aug 29, 2026

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Pharmaceutical companies are increasingly using telehealth digital waiting rooms as prime advertising slots. These virtual spaces offer unique opportunities for pharma brands to engage patients before and after their virtual care visits. The trend is driven by fresh data on patient attention and strategic execution by agencies.

  • 01Pharmaceutical brands are using digital waiting rooms in telehealth platforms as premium ad slots.
  • 02New patient-attention data enhances pharma media plans for virtual care settings.
  • 03Virtual waiting rooms allow targeted patient engagement before and after healthcare consultations.

Aug 29, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

CEO at Deerland Probiotics and Enzymes

Scott Ravitch is the CEO of Deerland Probiotics and Enzymes. He leads the company in providing innovative probiotic and enzyme solutions backed by robust clinical studies. Under his leadership, the company has focused on expanding its product portfolio and scientific research.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512